IDEXX beats Q1 earnings and revenue forecasts, raises 2021 guidance

IDEXX Laboratories Inc. (Nasdaq: IDXX) on Tuesday posted first-quarter results that surpassed market forecasts and raised its 2021 outlook to reflect expectations for higher organic revenue growth and better operating margins.

The Westbrook-based provider of veterinary diagnostics, veterinary practice software and water microbiology testing said that first-quarter revenue was $778 million, an increase of 24% on a reported basis and 21% higher organically over a year earlier. That exceeded the consensus forecast of analysts polled by Zacks Investment Research by 5.87%. Read more

Related Posts

Maine’s first mobile biolab starts tour of rural schools in Fort Kent

FORT KENT, Maine — Fort Kent middle schoolers are the state’s first students to learn at the newly unveiled Maine Mobile Biolab, a 50-foot,...

12 March 2024

UMaine Augusta’s $1.75M medical lab training facility doubles student capacity

Anew medical lab training facility on the campus of University of Maine Augusta is nearly six times larger than an off-campus space...

21 February 2024

UNE receives grant to research state-threatened animal

The University of New England has received a grant from the Maine Department of Inland Fisheries and Wildlife to study one...

12 February 2024